AltPep
Kekoa Knief has held various roles in the past seven years. In 2015, they were a Manager at Faraway Entertainment. In 2018, they were an Executive Administrator at Collision Consulting of Washington, providing consultation and appraisal services, consumer protection, and expert opinion services for trial and arbitration. In 2019, they were a Media and Marketing Manager at W.I.C.R.A., a non-profit organization aimed at legislative change within the automotive repair industry to protect consumers. Kekoa is currently an Office Manager at AltPep since 2022.
Kekoa Knief attended the University of Washington from 2014 to 2018, where they earned a Bachelor of Arts in Law, Societies, & Justice and Political Science.
AltPep
AltPep Corporation is a biomedical startup with a breakthrough approach for diagnosing and treating some of the world’s most intractable diseases: amyloid diseases. They are currently focusing on CNS disorders, in particular Alzheimer’s Disease (AD). They target and seek to neutralize the early toxic oligomers behind these amyloid diseases, which in the case of AD are due to aggregation of the Amyloid-beta peptide (Abeta).